6P Pembrolizumab plus chemotherapy vs chemotherapy in Asian patients with PD-L1 negative advanced NSCLC: Pooled analysis of KN021G, KN189 and KN407.

Authors :: Cheng, Y.
Yang, J.C-H.
Okamoto, I.
Zhang, L.
Hu, J.
Wang, D.
Hu, C.
Zhou, J.
Wu, L.
Cao, L.
Liu, J.
Zhang, H.
Sun, H.
Wang, Z.
Gao, H.
Yan, Y.
Xiao, S.
Lin, J.
Pietanza, M.C.
Kurata, T.
Source :: Annals of Oncology. 2021 Supplement 7, Vol. 32, pS1376-S1377. 2p.
Publication Year :: 2021

Subjects :: *ASIANS
*PROGRAMMED death-ligand 1
*CANCER chemotherapy
*NON-small-cell lung carcinoma
*PEMBROLIZUMAB

Full Text Access

Tools